HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Submit a response Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Mizuno, K. Articles by Araie, M. Search for Related Content PubMed PubMed Citation Articles by Mizuno, K. Articles by Araie, M.

Neuroprotective Effect and Intraocular Penetration of Nipradilol, a ß-Blocker with Nitric Oxide Donative Action

¹ From the Department of Pharmacology, Tokyo Research Laboratories, Kowa Company, Ltd., Tokyo, Japan; and the ² Department of Ophthalmology, University of Tokyo, School of Medicine, Japan.

PURPOSE. To investigate the effect of nipradilol, an ₁,ß-blocker with a nitric oxide donative action, on N-methyl-D-aspartate (NMDA)–induced retinal damage in rats and to determine whether topically instilled nipradilol penetrates the ipsilateral posterior retina–choroid at pharmacologically active concentrations in rabbits.

METHODS. To determine effects on NMDA-induced damage, drugs were injected alone or with NMDA into the vitreous of one eye, and cell loss in the ganglion cell layer (GCL) and thinning of the retinal neural cell layers were histologically evaluated. To evaluate posterior penetration, first, [¹⁴C]-nipradilol was instilled, and its tissue concentration was measured. Second, nipradilol or timolol was instilled, and their effects on intravitreal injection of endothelin-1–induced retinal artery contraction were compared, to evaluate whether a pharmacologically active level of nipradilol penetrates the inner limiting layer by topical application.

RESULTS. Intravitreous injection of NMDA reduced cell numbers in the GCL and the thickness of the inner plexiform layer (IPL) to 50.4% ± 2.6% and 47.8% ± 4.9% (n = 8) of control, respectively. Nipradilol alone had no effect. Coadministration of nipradilol with NMDA reduced cell numbers in the GCL and IPL thickness to 67.8% ± 2.2% and 74.4% ± 5.2% of control, respectively (P < 0.05–0.01). Sodium nitroprusside, but not timolol or bunazosin, also significantly prevented the NMDA-induced reduction of cell numbers in the GCL and IPL thickness. Radioactivity of nipradilol was found in the ipsilateral posterior retina–choroid at 318.6 ± 42.9 ng/g (n = 4), which was significantly higher than in the contralateral control (107.4 ± 21.8 ng/g). Topical application of nipradilol, but not timolol, significantly suppressed the endothelin-1–induced contraction of the retinal artery (83.95% ± 8.15% and 35.24% ± 5.62% of baseline vessel diameter for nipradilol and timolol, respectively).

CONCLUSIONS. Nipradilol suppressed the NMDA-induced retinal damage in rats for which nitric oxide released from nipradilol may be responsible. Posterior penetration studies suggested that an effective concentration of nipradilol reached the posterior retina after topical application.

This article has been cited by other articles:

				A. Iriyama, Y.-N. Chen, Y. Tamaki, and Y. Yanagi Effect of anti-VEGF antibody on retinal ganglion cells in rats Br. J. Ophthalmol., September 1, 2007; 91(9): 1230 - 1233. [Abstract] [Full Text] [PDF]

				H K F Yip, T Y Y Lai, K-F So, and A K H Kwok Retinal ganglion cells toxicity caused by photosensitising effects of intravitreal indocyanine green with illumination in rat eyes Br. J. Ophthalmol., January 1, 2006; 90(1): 99 - 102. [Abstract] [Full Text] [PDF]

				M. Ichikawa, Y. Okada, Y. Asai, H. Hara, K. Ishii, and M. Araie Effects of Topically Instilled Bunazosin, an {alpha}1-Adrenoceptor Antagonist, on Constrictions Induced by Phenylephrine and ET-1 in Rabbit Retinal Arteries Invest. Ophthalmol. Vis. Sci., November 1, 2004; 45(11): 4041 - 4048. [Abstract] [Full Text] [PDF]

				A. Iriyama, S. Uchida, Y. Yanagi, Y. Tamaki, Y. Inoue, K. Matsuura, K. Kadonosono, and M. Araie Effects of Indocyanine Green on Retinal Ganglion Cells Invest. Ophthalmol. Vis. Sci., March 1, 2004; 45(3): 943 - 947. [Abstract] [Full Text] [PDF]

				N. Toda and T. Okamura The Pharmacology of Nitric Oxide in the Peripheral Nervous System of Blood Vessels Pharmacol. Rev., June 1, 2003; 55(2): 271 - 324. [Abstract] [Full Text] [PDF]

				Y. Goto, N. Ibaraki, and K. Miyake Human Lens Epithelial Cell Damage and Stimulation of Their Secretion of Chemical Mediators by Benzalkonium Chloride Rather Than Latanoprost and Timolol Arch Ophthalmol, June 1, 2003; 121(6): 835 - 839. [Abstract] [Full Text] [PDF]

				K. Takahata, H. Katsuki, T. Kume, D. Nakata, K. Ito, S. Muraoka, F. Yoneda, S. Kashii, Y. Honda, and A. Akaike Retinal Neuronal Death Induced by Intraocular Administration of a Nitric Oxide Donor and Its Rescue by Neurotrophic Factors in Rats Invest. Ophthalmol. Vis. Sci., April 1, 2003; 44(4): 1760 - 1766. [Abstract] [Full Text] [PDF]

				K. Ishii, H. Matsuo, Y. Fukaya, S. Tanaka, H. Sakaki, M. Waki, and M. Araie Iganidipine, a New Water-Soluble Ca2+ Antagonist: Ocular and Periocular Penetration after Instillation Invest. Ophthalmol. Vis. Sci., March 1, 2003; 44(3): 1169 - 1177. [Abstract] [Full Text] [PDF]

				K. Mizuno, T. Koide, N. Saito, M. Fujii, M. Nagahara, A. Tomidokoro, Y. Tamaki, and M. Araie Topical Nipradilol: Effects on Optic Nerve Head Circulation in Humans and Periocular Distribution in Monkeys Invest. Ophthalmol. Vis. Sci., October 1, 2002; 43(10): 3243 - 3250. [Abstract] [Full Text] [PDF]